Seminari E - Search Results

1

Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors.

Seminari E, Maggiolo F, Villani P, Suter F, Pan A, Regazzi MB, Paolucci S, Baldanti F, Tinelli C, Maserati R. Seminari E, et al. J Acquir Immune Defic Syndr. 1999 Dec 15;22(5):453-60. doi: 10.1097/00126334-199912150-00005. J Acquir Immune Defic Syndr. 1999. PMID: 10961606 Clinical Trial.

2

A worldwide survey on perioperative antimicrobial prophylaxis for heart transplantation: From theory to clinical practice.

Seminari E, Ladini GS, Colaneri M, Chow J, Bruno R. Seminari E, et al. Transpl Infect Dis. 2023 Apr;25(2):e14034. doi: 10.1111/tid.14034. Epub 2023 Mar 6. Transpl Infect Dis. 2023. PMID: 36879517 Free article.

3

The possible role of serum bactericidal titres in long-term suppressive antibiotic treatment for infective endocarditis: report of three cases.

Valsecchi P, Calia M, Marvulli LN, Bono E, Monzillo V, Bruno R, Seminari E. Valsecchi P, et al. Among authors: seminari e. Infect Dis (Lond). 2023 Jul;55(7):514-518. doi: 10.1080/23744235.2023.2216271. Epub 2023 Jun 2. Infect Dis (Lond). 2023. PMID: 37264877 Free article.

4

[Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects].

Villani P, Cocchi L, Giacchino R, Seminari E, Regazzi MB, Maserati R. Villani P, et al. Among authors: seminari e. Clin Ter. 1996 Jun;147(6):279-93. Clin Ter. 1996. PMID: 8925637 Review. Italian.

5

[Clinical significance of diplopia in HIV infection. Assessment of a personal caseload and review of the literature].

Seminari E, Cocchi L, Antoniazzi E, Giacchino R, Maserati R. Seminari E, et al. Minerva Med. 1996 Nov;87(11):515-23. Minerva Med. 1996. PMID: 9045102 Review. Italian.

6

High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease.

Maserati R, Villani P, Seminari E, Pan A, Lo Caputo S, Regazzi MB. Maserati R, et al. Among authors: seminari e. AIDS. 1999 May 7;13(7):870-1. doi: 10.1097/00002030-199905070-00025. AIDS. 1999. PMID: 10357395 No abstract available.

7

High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma.

Villani P, Pregnolato M, Banfo S, Rettani M, Burroni D, Seminari E, Maserati R, Regazzi MB. Villani P, et al. Among authors: seminari e. Ther Drug Monit. 1999 Jun;21(3):346-50. doi: 10.1097/00007691-199906000-00018. Ther Drug Monit. 1999. PMID: 10365651 Clinical Trial.

8

Successful treatment of spleen tuberculosis in a patient with human immunodeficiency virus infection.

Maserati R, Seminari E, Scudeller L, Rizzi L, Benedetti M, Minoli L. Maserati R, et al. Among authors: seminari e. Monaldi Arch Chest Dis. 1999 Apr;54(2):130-2. Monaldi Arch Chest Dis. 1999. PMID: 10394826

9

Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters.

Lori F, Rosenberg E, Lieberman J, Foli A, Maserati R, Seminari E, Alberici F, Walker B, Lisziewicz J. Lori F, et al. Among authors: seminari e. AIDS Res Hum Retroviruses. 1999 Oct 10;15(15):1333-8. doi: 10.1089/088922299310034. AIDS Res Hum Retroviruses. 1999. PMID: 10515148

10

Hydroxyurea toxicity combined with didanosine (ddl) in HIV-1-seropositive asymptomatic individuals.

Seminari E, Lisziewicz J, Tinelli C, Foli A, Lori F, Maserati R. Seminari E, et al. Int J Clin Pharmacol Ther. 1999 Oct;37(10):514-8. Int J Clin Pharmacol Ther. 1999. PMID: 10543320 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters